Thousands of clients in the United States and Europe rely on Transplant Solutions, LLC, to meet their medical needs and reduce costs. They work with a multidisciplinary team of physicians and staff to optimize the quality and efficiency of transplant surgeries. The company's expertise in this area has earned it the reputation of an industry leader. Read on for more information. This article explains how transplants work and what you can expect from a partner. Get more details about transplant solutions on this page. Global Transplant Solutions is a Duncan, BC-based company that focuses on organ transportation and preservation. Founded in 2007, the company has blazed a trail in the medical field. In just four years, it has developed a portfolio of products for the transplant market in Canada. The company has received FDA clearance for two of its products and has four more awaiting approval. The goal of the company is to create the most effective transplant options possible for patients. Bill Ross began his career playing with Medicare as a consultant for Aetna Life Insurance Company. He served as the administrator of the Part A field office and the End-Stage Renal Disease Reimbursement Program, as well as independent organ procurement agencies. In between, he worked for several companies, including as a Vice President of reimbursement at LifeLink Foundation and Chief Operating Officer of Guidry and East. He joined Transplant Solutions in 2015 and now serves as Executive Chairman. Pure Transplant Solutions is another South Carolina-based biotechnology firm that develops HLA-based therapeutics and diagnostics for organ transportation. In addition to this, the company has entered into a research collaboration with the University Hospital of Basel. This partnership will lead to new diagnostics for DSA monitoring and characterization. The two companies also plan to expand their partnership by providing additional funding to GTS. The company has a strong leadership team and a proven track record of improving the lives of kidney failure patients. The company is part of the South Carolina Research Authority (SCRA), a public nonprofit corporation that supports innovation and entrepreneurship. In addition to funding, GTS has received $350,000 in investments from SC Launch, a nonprofit organization that provides loans and investments to South Carolina-based companies. According to Steve Johnson, the investment from SC Launch has increased by nearly four-fold since the company was founded in 2010. With this investment, Transplant Solutions has expanded its pipeline and is ready to serve patients worldwide. Another biotechnology company that is developing HLA-based therapeutics and diagnostics for transplants is Pure Transplant Solutions. This company has invested $350,000 in GTS, which is a biotechnology startup that aims to improve the lives of patients with kidney disease. Its goal is to reduce the need for dialysis and reduce healthcare costs by providing earlier access to transplantation. The company also provides the healthcare community with clear savings through the partnership. For more information, check out this related post: https://en.wikipedia.org/wiki/Digital_health.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |